"DH"B

Sachin Kushwaha1, Pratiksha Shome1, Devinder Sehgal1

  • 1Molecular Immunology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India.

ImmunoHorizons
|August 2, 2024
PubMed
概括

糖结合物疫苗的增强剂量导致对多糖的抗体反应受到限制,与对载体蛋白的多样性反应不同. 这表明,抗原驱动的选择塑造了抗体谱,影响了疫苗的设计.